1-20 of 20
Rosa Sapena
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II Clinical Trial Evaluating Azacitidine + Venetoclax + Donor Lymphocyte Infusion in Post-Transplant Relapse Myelodysplastic Syndromes and Acute Myeloid Leukemia: Preliminary Results of Ventograft, a GFM Study

Thomas Cluzeau, Marie Sebert, Michael Loschi, Lionel Ades, Sylvain Thepot, Martin Carre, Nicolas Duployez, Rosa Sapena, Fatiha Chermat, Claude Preudhomme, Pierre Fenaux, Marie Robin
Journal: Blood
Blood (2023) 142 (Supplement 1): 3246.
https://doi.org/10.1182/blood-2023-178021
Published: 2023
Journal Articles

FLT3 Ligand Kinetic Profile Predicts Response to Treatment and Event-Free Survival (EFS) in Adults with High-Risk MDS/CMML Receiving CPX-351: A GFM Study

Pierre Peterlin, Joëlle Gaschet, Pascal Turlure, Marie-Pierre Gourin, Pierre-Yves Dumas, Sylvain Thepot, Ana Berceanu, Sophie Park, Marie Anne Hospital, Thomas Cluzeau, Jose-Miguel Torregrosa-Diaz, Louis Drevon, Rosa Sapena, Fatiha Chermat, Sophie Dimicoli-Salazar, Maxime Jullien, Pierre Fenaux, Patrice Chevallier
Journal: Blood
Blood (2023) 142 (Supplement 1): 6469.
https://doi.org/10.1182/blood-2023-173741
Published: 2023
Journal Articles

Molecular Response Analysis By High Throughput Sequencing in Higher Risk Myelodysplastic Syndrome (HR-MDS) Treated Intensively with CPX-351

Yannick Le Bris, Simon Bouzy, Audrey Ménard, Pascal Turlure, Patrice Chevallier, Marie-Pierre Gourin, Pierre-Yves Dumas, Sylvain Thepot, Anna Berceanu, Sophie Park, Marie-Anne Hospital, Thomas Cluzeau, Jose-Miguel Torregrosa Diaz, Louis Devron, Rosa Sapena, Fatiha Chermat, Sophie Dimicoli Salazar, Marie C Béné, Pierre Fenaux, Pierre Peterlin
Journal: Blood
Blood (2022) 140 (Supplement 1): 9821–9823.
https://doi.org/10.1182/blood-2022-162278
Published: 2022
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (allo HSCT) in Patients with IPSS Low or Intermediate-1 Myelodysplastic Syndrome (MDS): A Prospective Multicenter Phase II Study Based on Donor Availability By the GFM & SFGM-TC "MDS-ALLO-Risk"

Marie Sebert, Cendrine Chaffaut, Sylvain Thepot, Corentin Orvain, Thomas Cluzeau, Michael Loschi, Pierre Peterlin, Patrice Chevallier, Maud d'Aveni, Marie-Thérèse Rubio, Odile Beyne Rauzy, Anne Huynh, Amandine Charbonnier, Nathalie Fegueux, Gaelle Fossard, Stephanie N'guyen-Quoc, Sophie Park, Rosa Sapena, Fatiha Chermat, Lionel Ades, Sylvie Chevret, Pierre Fenaux, Marie Robin
Journal: Blood
Blood (2021) 138 (Supplement 1): 1842.
https://doi.org/10.1182/blood-2021-146846
Published: 2021
Journal Articles

CPX 351 As First Line Treatment in Higher Risk MDS. a Phase II Trial By the GFM

Pierre Peterlin, Pascal Turlure, Patrice Chevallier, Marie-Pierre Gourin, Pierre-Yves Dumas, Sylvain Thepot, Anna Berceanu, Sophie Park, Marie Anne Hospital, Thomas Cluzeau, Jose Miguel Torregrosa Diaz, Louis Devron, Sylvie Chevret, Marie C Bene, Yannick Le Bris, Rosa Sapena, Fatiha Chermat, Sophie Dimicoli-Salazar, Pierre Fenaux
Journal: Blood
Blood (2021) 138 (Supplement 1): 243.
https://doi.org/10.1182/blood-2021-145123
Published: 2021
Journal Articles

A Molecular-Based Response Prediction Model to Romiplostim in Patients with Lower-Risk Myelodysplastic Syndrome and Severe Thrombocytopenia

Anne Sophie Kubasch, Aristoteles Giagounidis, Georgia Metzgeroth, Anna Jonasova, MD PhD, Regina Herbst, MD, Jose Miguel Torregrosa Diaz, Benoit De Renzis, MD, Katharina S. Götze, Marie-Luise Huetter-Kroenke, MD, Marie-Pierre Gourin, Bohrane Slama, MD, Sophie Dimicoli-Salazar, MD, Pascale Cony-Makhoul, MD, Kamel Laribi, MD, Sophie Park, MD PhD, Katja Jersemann, Dorothea Schipp, Klaus H. Metzeler, MD, Oliver Tiebel, MD, Katja Sockel, MD, Silke Gloaguen, Msc, Anna Mies, Fatiha Chermat, Christian Thiede, MD, Rosa Sapena, Richard F. Schlenk, Pierre Fenaux, MD PhD, Uwe Platzbecker, Lionel Ades, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-139291
Published: 2020
Journal Articles

Decitabine Versus Hydroxyurea for Advanced Proliferative CMML: Results of the Emsco Randomized Phase 3 Dacota Trial

Raphael Itzykson, MD PhD, Valeria Santini, Cendrine Chaffaut, Ades Lionel, Sylvain Thepot, MD, Aristoteles Giagounidis, Margot Morabito, Nathalie Droin, Michael Luebbert, Rosa Sapena, Stanislas Nimubona, MD, Jean E. Goasguen, MD PhD, Eric Wattel, MD PhD, Gina Zini, MDPhD, Jose Miguel Torregrosa Diaz, Ulrich Germing, Anna Maria Pelizzari, Sophie Park, MD PhD, Nadja Jaekel, Georgia Metzgeroth, Francesco Onida, MD, Robert Navarro, Andrea Patriarca, MD, Aspasia Stamatoulas Bastard, MD, Martin Puttrich, Sandra Mossuto, Eric Solary, MD PhD, Silke Gloaguen, Msc, Sylvie Chevret, MD PhD, Fatiha Chermat, Uwe Platzbecker, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 53–54.
https://doi.org/10.1182/blood-2020-138680
Published: 2020
Journal Articles

Eltrombopag in Chronic Myelomonocytic Leukemia (CMML) with Severe Thrombocytopenia: Final Results of a Multicenter Phase II Study

Florence Rabian, MD, Jérôme Lambert, Daniela Barbieri, Berengere Gruson, MD, Sylvain Thepot, MD, Thorsten Braun, MD PhD, Norbert Vey, MD, Jacques Delaunay, MD, Laurence Legros, PhD MD, Julie Lejeune, Anouk Walter-petrich, Rosa Sapena, Nathalie Droin, PhD, Fatiha Chermat, Francoise Porteu, Daniel Lusina, Lionel Ades, MDPhD, Eric Solary, MD PhD, Pierre Fenaux, MDPhD, Raphael Itzykson, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-137469
Published: 2020
Journal Articles

Biomarkers of Response to Romiplostim in Patients with Lower-Risk Myelodysplastic Syndrome (MDS) and Thrombocytopenia - Results of the Europe Trial By the Emsco Network

Uwe Platzbecker, MD, Anne Sophie Kubasch, MD, Aristoteles Giagounidis, MD, Georgia Metzgeroth, Anna Jonasova, MD PhD, Regina Herbst, MD, Jose Miguel Torregrosa Diaz, Benoit De Renzis, MD, Katharina Götze, Marie-Luise Huetter-Kroenke, MD, Marie-Pierre Gourin, Borhane Slama, MD, Sophie Dimicoli-Salazar, MD, Pascale Cony-Makhoul, MD, Kamel Laribi, MD, Sophie Park, MD PhD, Katja Jersemann, Oliver Tiebel, MD, Katja Sockel, MD, Silke Gloaguen, MSc, Anna Mies, Fatiha Chermat, Christian Thiede, MD, Rosa Sapena, Richard F. Schlenk, MD, Pierre Fenaux, MD PhD, Lionel Ades, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2998.
https://doi.org/10.1182/blood-2019-129047
Published: 2019
Journal Articles

A Phase II Trial of Eltrombopag in Chronic Myelomonocytic Leukemia (CMML) with Thrombocytopenia

Raphael Itzykson, MD PhD, Jérôme Lambert, MDPhD, Daniela Barbieri, Berengere Gruson, Sylvain Thepot, MD, Thorsten Braun, MD PhD, Norbert Vey, Jacques Delaunay, MD, Laurence Legros, MD PhD, Julie Lejeune, Rosa Sapena, Nathalie Droin, Francoise Porteu, Eric Solary, MD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4266.
https://doi.org/10.1182/blood.V130.Suppl_1.4266.4266
Published: 2017
Journal Articles

Additional Prognostic Impact of the Percentage of Erythroid Cells in the Bone Marrow of MDS Patients

Judith Neukirchen, MD, Heinz Tuechler, Matteo Giovanni Della Porta, MD, Pierre Fenaux, MD PhD, Ulrich Germing, MD, Agnès Guerci, Kathrin Nachtkamp, MD, Marianna Rossi, MD, Rosa Sapena, Wolfgang R. Sperr, MD, Corinna Strupp, MD, Aspasia Stamatoullas, MD, Peter Valent, MD, John M. Bennett, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4259.
https://doi.org/10.1182/blood.V130.Suppl_1.4259.4259
Published: 2017
Journal Articles

Results of a Phase II Study of Guadecitabine (SGI-110) in Higher Risk MDS, CMML or Low Blast Count AML Patients Refractory to or Relapsing after Azacitidine (AZA) Treatment

Marie Sebert, MD, Cecile Bally, Pierre Peterlin, MD, Odile Beyne-Rauzy, MD PhD, Laurence Legros, MDPhD, marie Pierre Gourin, MD PhD, Laurence Sanhes, MD, Eric Wattel, MDPhD, Emmanuel Gyan, MD PhD, Sophie Park, MD PhD, Aspasia Stamatoullas, MD, Anne Banos, Kamel Laribi, Simone Jueliger, PhD, Luke Bevan, Cendrine Chaffaut, Rosa Sapena, Benedicte Samey, Fatiha Chermat, Sylvie Chevret, Lionel Ades, MD PhD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2016) 128 (22): 347.
https://doi.org/10.1182/blood.V128.22.347.347
Published: 2016
Journal Articles

MDS with Isolated Trisomy 8. a Type of MDS Frequently Associated with Myeloproliferative Features? A Report from the GFM

Louis Drevon, Alice Marceau, Virginie Eclache, S. Dominique Raynaud, MD, Valentine Richez, Inès Berkaoui, Odile Maarek, Wendy Cuccuini, Daniel Lusina, Celine Berthon, Sophie Dimicoli-Salazar, Audrey Bidet, Jean-Philippe Vial, Sophie Park, MD PhD, Aspasia Stamatoullas, MD, Christina Vieira Dos Santos, Thorsten Braun, MD PhD, Rosa Sapena, Aline Renneville, Lionel Ades, MD PhD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2881.
https://doi.org/10.1182/blood.V126.23.2881.2881
Published: 2015
Journal Articles

Outcome of Lower Risk Non Del 5q MDS after Failure of Erythropoiesis Stimulating Agents (ESA), and Impact of Post-ESA Treatment on Survival: A Retrospective European Study

Sophie Park, MD PhD, Jean-François Hamel, Andrea Toma, Charikleia Kelaidi, MD, Maria Campelo Diez, Valeria Santini, MD, Enrico Balleari, MD, Jennifer Schemenau, Rosa Sapena, Katharina Goetze, MD, Catharina Mueller-Thomas, MD, Odile Beyne-Rauzy, MD PhD, Aspasia Stamatoullas, MD, Ioannis Kotsianidis, Agnes Guerci, MD, Dominique Bordessoule, Pascale Cony-Makhoul, MD, Stéphane Cheze, MD PhD, Eric Wattel, MDPhD, Christian Rose, Norbert Vey, Ulrich Germing, MD, Guillermo Sanz, MD PhD, François Dreyfus, MD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1665.
https://doi.org/10.1182/blood.V126.23.1665.1665
Published: 2015
Journal Articles

The Revised IPSS (IPSS-R) Predicts Response To Erythropoietic Stimulating agents (ESA) In Pts With Classical IPSS Low Or Intermediate-1 (int 1)- MDS: A Joint Retrospective Study Of The GFM, Düsseldorf Registry and Fism

Valeria Santini, Jennifer Schemenau, MD, Alessandro Levis, Enrico Balleari, MD, Rosa Sapena, Lionel Ades, Agnès Guerci, Odile Beyne-Rauzy, MD, PhD, Marie Pierre Gourin, Stéphane Cheze, Aspasia Stamatoullas, MD, Alessandro Sanna, MD, Daniela Gioia, Giani Cametti, MD, Dario Ferrero, MD, Emmanuel Raffoux, Christian Rose, MD, Poloni Antonella, MD, Thomas Prebet, MD, PhD, Shanti Ame, MD, Laurence Legros, MD, PhD, Pierre Fenaux, MD, PhD, Ulrich Germing, MD, Francois Dreyfus, MD, Sophie Park
Journal: Blood
Blood (2013) 122 (21): 2761.
https://doi.org/10.1182/blood.V122.21.2761.2761
Published: 2013
Journal Articles

Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

Valeria Santini, Jennifer Schemenau, Alessandro Levis, Enrico Balleari, Rosa Sapena, Lionel Adès, Agnès Guerci, Odile Beyne-Rauzy, Marie-Pierre Gourin, Stephane Cheze, Aspasia Stamatoullas, Alessandro Sanna, Daniela Gioia, Gianni Cametti, Dario Ferrero, Emmanuel Raffoux, Christian Rose, Antonella Poloni, Thomas Prebet, Laurence Legros, Shanti Natarajan-Amé, Pierre Fenaux, Ulrich Germing, François Dreyfus, Sophie Park
Journal: Blood
Blood (2013) 122 (13): 2286–2288.
https://doi.org/10.1182/blood-2013-07-512442
Published: 2013
Journal Articles

Should Immunosuppressive Therapy (IST) Be Used More Often In Lower Risk MDS?

Sophie Cereja, Sabine Brechignac, Lionel Ades, Thorsten Braun, Simone Boehrer, Zehaira Hebibi, Rosa Sapena, Odile Beyne-Rauzy, Norbert Vey, Herve Dombret, Dominique Bordessoule, Francois Dreyfus, Pierre Fenaux, Claude Gardin
Journal: Blood
Blood (2010) 116 (21): 1868.
https://doi.org/10.1182/blood.V116.21.1868.1868
Published: 2010
Journal Articles

Long-Term Outcome of Anemic Non Del 5q Lower-Risk MDS Refractory to or Relapsing After Erythropoiesis Stimulating Agents (ESAs)

Charikleia Kelaidi, Sophie Park, Rosa Sapena, Odile Beyne-Rauzy, Valérie Coiteux, Norbert Vey, Aspasia Stamatoullas, Bachra Choufi, Jacques Delaunay, Marie-Pierre Gourin, Stéphane Cheze, Christophe Ravoet, Augustin Ferrant, Martine Escoffre-Barbe, Linda Aljassem, Emmanuel Raffoux, Raphael Itzykson, Lionel Ades, Francois Dreyfus, Pierre Fenaux
Journal: Blood
Blood (2010) 116 (21): 442.
https://doi.org/10.1182/blood.V116.21.442.442
Published: 2010
Journal Articles

Correlation Between serum ferritin Level at diagnosis and Survival In Lower Risk, Non-Transfusion Dependent, MDS Patients.A Report by the Groupe Francophone Des Myelodysplasies (GFM)

Sophie Park, MD, PhD, Rosa Sapena, Dominique Vassilieff, Charikleia Kelaidi, Dominique Bordessoule, Aspasia Stamatoullas, Stéphane Cheze, Odile Beyne-Rauzy, Norbert Vey, MD, Christian Rose, Agnès Guerci, Shanti Ame, Gerard Tertian, Borhane Slama, MD, Pierre Fenaux, Francois Dreyfus
Journal: Blood
Blood (2010) 116 (21): 2916.
https://doi.org/10.1182/blood.V116.21.2916.2916
Published: 2010
Journal Articles

Early Treatment of Anemia of Lower Risk MDS by Erythropoiesis-Stimulating Agents (ESAs): A Report On 112 Cases.

Sophie Park, MD, PhD, C. Kelaidi, Rosa Sapena, D. Vassilieff, Odile Beyne-Rauzy, Valerie Coiteux, MD, Norbert Vey, Christophe Ravoet, Stéphane Cheze, Christian Rose, Laurence Legros, MD, PhD, Aspasia Stamatoullas, Martine Escoffre-Barbe, MD, Agnes Guerci, MP Chaury, Pierre Fenaux, Francois Dreyfus
Journal: Blood
Blood (2009) 114 (22): 1765.
https://doi.org/10.1182/blood.V114.22.1765.1765
Published: 2009